Meeder Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5
| Closed | – | – | 2431 |
|
|
2021
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1795 |
|
|
2018
Q4 | – | Sell |
-2,029
| Closed | -$4K | – | 1757 |
|
|
2018
Q3 | $4K | Buy |
+2,029
| New | +$4K | ﹤0.01% | 1368 |
|
|
2018
Q1 | – | Sell |
-162
| Closed | – | – | 1649 |
|
|
2017
Q4 | $0 | Buy |
+162
| New | – | ﹤0.01% | 1728 |
|
|
2017
Q3 | – | Sell |
-253
| Closed | -$1K | – | 1699 |
|
|
2017
Q2 | $1K | Sell |
253
-749
| -75% | -$2.96K | ﹤0.01% | 1526 |
|
|
2017
Q1 | $3K | Buy |
+1,002
| New | +$3K | ﹤0.01% | 1264 |
|